5-iodotubercidin has been researched along with Leucocythaemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Awar, R; Arrowsmith, CH; Bolshan, Y; Brown, PJ; Fedorov, O; Knapp, S; Li, F; Nguyen, KT; Schapira, M; Smil, D; Tempel, W; Vedadi, M; Yu, W | 1 |
Canaani, E; Croce, CM; Nakamura, T; Nakanishi, H | 1 |
2 other study(ies) available for 5-iodotubercidin and Leucocythaemia
Article | Year |
---|---|
Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
Topics: Crystallography, X-Ray; Halogenation; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Methyltransferases; Models, Molecular; S-Adenosylhomocysteine | 2013 |
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias.
Topics: Acute Disease; Apoptosis; Cell Line, Tumor; Chromosomes, Human, Pair 4; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Genome, Human; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Receptor, EphA7; Transcription, Genetic; Tubercidin | 2007 |